Staphylococcus aureus infection of mice expands a population of memory ?? T cells that are protective against subsequent infection.

ABSTRACT: The development of vaccines against Staphylococcus aureus has consistently failed in clinical trials, likely due to inefficient induction of cellular immunity. T cell-derived IL-17 is one of the few known correlates of antistaphylococcoal immunity, conferring protection against S. aureus infections through its ability to promote phagocytic cell effector functions. A comprehensive understanding of the discrete T cell subsets critical for site-specific IL-17-mediated bacterial clearance will therefore be necessary to inform the development of vaccines that efficiently target cellular immunity. In this study, we have identified a population of CD44+ CD27- memory ?? T cells, expanded upon infection of C57BL/6 mice with S. aureus, which produce high levels of IL-17 and mediate enhanced bacterial clearance upon reinfection with the bacterium. These cells are comprised largely of the V?4+ subset and accumulate at the site of infection subsequent to an initial V?1.1+ and V?2+ T cell response. Moreover, these V?4+ T cells are retained in the peritoneum and draining mediastinal lymph nodes for a prolonged period following bacterial clearance. In contrast to its critical requirement for ?? T cell activation during the primary infection, IL-1 signaling was dispensable for activation and expansion of memory ?? T cells upon re-exposure to S. aureus. Our findings demonstrate that a ?? T cell memory response can be induced upon exposure to S. aureus, in a fashion analogous to that associated with classical ?? T cells, and suggest that induction of IL-17-expressing ?? T cells may be an important property of a protective vaccine against S. aureus.

SUBMITTER: Murphy AG 

PROVIDER: S-EPMC3979672 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature